What is the study about?
We are recruiting individuals between the ages of 18-70 who are suffering from androgenic alopecia to see if they qualify to participate in a clinical study involving the assessment and treatment of androgenic alopecia (AGA).
Androgenic alopecia is a chronic, nonscarring, age-related disorder that is marked by a progressive reduction in the diameter, length, and pigmentation of the hair. The hair loss or balding is typically located on the central scalp may be present with other various patterns of hair loss as well and is generally thought to be related to genetics and hormone levels. Symptoms include increased hair shedding, transition in the involved areas from large, thick, pigmented hairs to thinner, shorter, indeterminate hairs and finally to short wispy nonpigmented hairs.
Our study is being performed so that we may compare the efficacy of PRP and stem cells vs the combination therapy of PRP and stem cells with light therapy. PRP contains a concentration of various growth factors that stimulate regenerative cells in the microenvironment of the hair follicle by activating the growth phase and accelerating the cellular growth of miniaturized hairs, whereas light therapy has shown to accelerate blood flow and enhance protein synthesis. These non-invasive therapies have been shown to provide tremendous improvement of AGA. We encourage our participants to enroll in this exciting and beneficial study for those who are looking for fuller thicker hair.
Where is it located?
Our physician partner in San Francisco, CA will reach out to you with the details if you qualify.
Do I Qualify?
To find out if you qualify fill out the registration form located at